🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
Chronic rhinosinusitis is a common disease that effects millions of people ...
Status
Completed
Location
Loma Linda University Medical Center
Start Date
2015-08
Trial ID
NCT02927834
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
Steroid is commonly used to treat autoimmune disorders such as rheumatoid a...
Status
Completed
Location
Pacific Gastroenterology Associates
Start Date
2013-10
Trial ID
NCT01981889
Treatments Being Tested
This phase II trial is studying how well giving combination chemotherapy to...
Status
Completed
Location
SWOG
Start Date
2005-06
Trial ID
NCT00121199
This protocol is an international, multicenter, comparative, open and rando...
Status
Unknown
Location
Hospital Universitário Clementino Fraga Filho
Start Date
2007-01
Trial ID
NCT01532856
This will be a 5 year randomized, double blind, placebo controlled trial of...
Status
Completed
Location
The Governers of The University of Calgary - Alberta Health Services
Start Date
2017-05-01
Trial ID
NCT03070522
Treatments Being Tested
This randomized phase III trial studies enzalutamide to see how well it wor...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-22
Trial ID
NCT01949337
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested